Deals & Capital Markets
Sanofi Pays $2.2 Billion for Dynavax in Bet on Adult Vaccines Amid Policy Uncertainty
Dec 25, 2025
You're signed outSign in or to get full access.
DYNAVAX TECHNOLOGIES (DVAX) Earnings Call Transcripts
Browse quarterly earnings call transcripts for DYNAVAX TECHNOLOGIES.
Q3 2025
Nov 5, 2025
Q2 2025
Aug 7, 2025
Q1 2025
May 6, 2025
Q4 2024
Feb 20, 2025
Q3 2024
Nov 7, 2024
